Apollomics
Presence
Apollomics is a company listed under the stock ticker APLM (US).
Executives
View the org chart displaying its 11 main executives
Most searched biographies at Apollomics
- Guo-liang Yu, Executive Director, Chairman and Chief Executive Off...
- Kenneth Carter, Independent Director
- Glenn Vraniak, Independent Director
Popular executive movements at Apollomics
- Matthew Plunkett has joined the company as Chief Financial Officer (posted on March 5 2024).
Create your alert
to follow the executive moves at Apollomics.
Biotechnology
Apollomics has 2,275 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).
Popular M&A news in Biotechnology
- Bruker has announced the acquisition of NanoString Technologies (posted on April 18 2024).
- Vertex Pharmaceuticals has announced the acquisition of Alpine Immune Sciences (posted on April 16 2024).
- Nurix Therapeutics has just announced a $175 Million fundraising (posted on April 13 2024).
Popular contacts in Biotechnology
News
Press releases by Apollomics
- Apollomics Announces the First Approval of Vebreltinib for MET Exon 14 Skip Non-Small Cell Lung Cancer | Apollomics, Inc.
- Apollomics Announces Report of Activity of Vebreltinib in Glioblastoma Multiforme (GBM) with PTPRZ-MET Fusion | Apollomics, Inc.
- Apollomics Announces Efficacy of Vebreltinib in NSCLC Patients with MetEx14 Skipping Mutation Achieving an Overall Response Rate (ORR) of 75% | Apollomics, Inc.
- Apollomics Announces Two New Cohorts in Global Phase 2 SPARTA Study of Vebreltinib in Non-Small Cell Lung Cancer and Other Solid Tumors with MET Dysregulation | Apollomics, Inc.
- Apollomics Reports First Half 2023 Financial Results and Provides Corporate Update | Apollomics, Inc.
- Apollomics Announces Presentations of Vebreltinib Data at ESMO 2023 | Apollomics, Inc.
- Apollomics to Present at the H.C. Wainwright 25th Annual Global Investment Conference | Apollomics, Inc.
- Presentations | Apollomics, Inc.
- Apollomics, a Company Developing Novel Oncology Therapies to Address Difficult-to-Treat Cancers, Announces Closing of Business Combination and Listing on Nasdaq | Apollomics, Inc.
- Apollomics Co-Founder and President, Sanjeev Redkar, Ph.D., to Speak at 23rd Annual R. Bryan Miller Symposium | Apollomics, Inc.
- View more press releases Close
Social media about Apollomics
- Apollomics on Wikipedia, Google News & Yahoo Finance
- Apollomics on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Matthew Plunkett 
